Clinical trials recruiting for Hematologic Malignancies
Fewer than 3 recruiting trials found.
2
Recruiting trials
1
US states with sites
1
Countries
50%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| GVHD prophylaxis | 1 |
| Maraviroc | 1 |
| Plerixafor | 1 |
| RIC | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 2 |
Top cities
Self-screener
Recruiting trials
- Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
- Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Related conditions
Trials recruiting for Hematologic Malignancies often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Hematologic Malignancies trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.